AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02964572 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glimepiride
Description: In accordance with the standard treatment guidelines of diabetes, glimepiride as a drug of active comparator will be administered to improve blood sugar in patients with poorly controlled blood sugar.
Study NCT03307720 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gonadotropin Releasing Hormone Agonists (GNRH-A)
Description: Administration of a gonadotropin releasing hormone agonist (GnRH-a) (0,2 ml) subcutaneously, 36 hours before ovum pick-up in IVF treatments.
Study NCT03307720 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Human chorionic gonadotropin
Description: Administration of Human chorionic gonadotropin (HCG) 250 IU subcutaneously , 36 hours before ovum pick-up in IVF treatments.
Study NCT00385866 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: cancer screening and health education
Description: The control group will receive cancer screening and health education materials on a quarterly basis but will not have access to patient navigation services.
Study NCT00385866 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: facilitation of Services to improve cancer screening
Description: The intervention group will receive cancer education and faciliation of services in the form of patient navigation
Study NCT02964572 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Description: Empagliflozin as a drug of experimental will be administered to improve blood sugar in patients with poorly controlled blood sugar.
Study NCT02186444 — intervention group
Intervention type: OTHER
Intervention: Personalized Health Information Navigator (PHIN)
Description: The application (or app) titled Personalized Health Information Navigator (PHIN) is an interactive psycho-educational intervention that will be delivered via mobile tablet technology. The PHIN provides patient-centered education. At the first meeting, the community navigator will provide a visual demonstration of PHIN on the Apple iPad. The community navigator will leave the iPad with the participant for 6-weeks and will stress the importance of using the PHIN app to address any educational or psychosocial needs.
Study NCT02186444 — intervention group
Intervention type: OTHER
Intervention: NCI Information Booklets (IB)
Description: Participants will receive a packet of information booklets (What You Need to Know About Prostate Cancer; Taking Time: Support for People with Cancer; and Facing Forward, Life After Cancer Treatment) that address prostate cancer treatment options, the late and long term effects, follow-up care, and sources of support. At the first meeting, the community navigator will provide a review of the print materials and stress the importance of reading the booklets carefully to help prepare for the discussion with your healthcare provider. The community navigator will leave the print materials with the participant for 6-weeks.
Study NCT00766779 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: hematopoietic cell transplantation
Description: low dose total body irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors
Study NCT00766779 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Non-Transplant treatment approach for consolidation
Description: Patients will receive the treatment that would be otherwise applied at the local institution. The consolidation or maintenance therapy is according to the study group protocol.
Study NCT00418587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cholecalciferol
Description: 800 IU oral daily
Study NCT00418587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cholecalciferol
Description: 2000 IU oral daily
Study NCT00418587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cholecalciferol
Description: 4000 IU oral daily
Study NCT00870194 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: exenatide and sitagliptin
Description: exenatide-subcutaneous injection, 5mcg (4 weeks) followed by 10mcg (16 weeks), twice a day; sitagliptin-100mg tablet orally once a day
Study NCT01886144 — intervention group
Intervention type: DEVICE
Intervention: Knee OA Brace
Study NCT00870194 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: exenatide and placebo
Description: exenatide-subcutaneous injection, 5mcg (4 weeks) followed by 10mcg (16 weeks), twice a day; placebo-tablet orally once a day
Study NCT04031872 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3200882
Description: Combination treatment with LY3200882 and capecitabine
Study NCT01986972 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Toothbrushing With Dentifrice
Description: The participants were instructed to interrupt any chemical and/or mechanical oral hygiene procedure for 72 hours. Dental plaque was stained by a 2% erithrosin solution, followed by a mouth rinsing with water for 1 minute. Next, the set of dental quadrants (1-3 and 2-4) were randomly allocated to experimental groups by the flip of a coin. One of the sets was brushed with multi bristle brush without the use of dentifrice and the second set was brushed with multi bristle brush using dentifrice. Toothbrushing was performed by the individual's regular technique timed. Two minutes was used for each set. After toothbrushing, the dental biofilm was again stained and evaluated by the same examiner, who was blind to the quadrants brushed with or without dentifrice.
Study NCT01986972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Toothbrushing Without Dentifrice
Description: The participants were instructed to interrupt any chemical and/or mechanical oral hygiene procedure for 72 hours. Then, dental plaque was stained by a 2% erithrosin solution, followed by a mouth rinsing with water for 1 minute. Next, the set of dental quadrants (1-3 and 2-4) were randomly allocated to experimental groups by the flip of a coin. One of the sets was brushed with multi bristle brush without the use of dentifrice and the second set was brushed with multi bristle brush using dentifrice. Toothbrushing was performed by the individual's regular technique timed. Two minutes was used for each set. After toothbrushing, the dental biofilm was again stained and evaluated by the same examiner, who was blind to the quadrants brushed with or without dentifrice.
Study NCT03946865 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reiki Therapy
Description: Reiki is a healing practice that originated in Japan. Reiki practitioners place their hands lightly on or just above the person receiving treatment, with the goal of facilitating the person's own healing response.
Study NCT03600454 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: General anesthesia
Description: The induction of general anesthesia will be delivered in a standardized manner with the intravenous administration of fentanyl 2µg/kg and propofol
Study NCT03600454 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia
Description: The level of puncture will be L4 - L5. 10 mg bupivacaine will be injected in the subarachnoid space, after spontaneous surge of cerebrospinal fluid
Study NCT03600454 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: General anesthesia and epidural analgesia
Description: The induction of general anesthesia will be delivered in a standardized manner with the intravenous administration of fentanyl 2 µg/kg and propofol. A thoracic epidural catheter will be placed with 3 ml of xylocaine 2% (with epinephrine 1/200.000).
Study NCT03494218 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Nociception Coma Scale (NCS)
Description: Patients have been assessed with both the Nociception Coma Scale (NCS) and the FLACC.
Study NCT02714270 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: modified partograph
Study NCT02714270 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: paperless partograph
Study NCT02102152 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tobramycin
Study NCT00005632 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MUC1-KLH vaccine/QS21
Study NCT03239847 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EndoPhys Sheath and Radial Arterial Line
Study NCT03239847 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EndoPhys Sheath
Study NCT02004015 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: injection of placebo
Description: 0.5 mg/kg milligram(s)/kilogram
Study NCT02004015 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: injection of NMBA
Study NCT01679509 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic adnexal surgery
Study NCT01679509 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Three-port laparoscopic adnexal surgery
Study NCT03912545 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Quantra System
Description: Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.
Study NCT02502513 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief computerized intervention
Description: Computer game Tetris
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: asparaginase
Description: Given IV during reinduction
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Given IV during reinduction
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytarabine
Description: Given IV during reinduction
Study NCT02506829 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling (Quitline)
Study NCT02506829 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Smoking cessation counseling (Quitline)
Study NCT02506829 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)
Study NCT02506829 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy)
Study NCT01002469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: sodium [1-13C] acetate
Study NCT00304564 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Listening
Description: subjects listen to music
Study NCT02532647 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam
Study NCT02532647 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam
Study NCT02532647 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02506829 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial incentives
Study NCT00736632 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3
Description: Cholecalciferol 4000 units orally daily Calcium carbonate 500 mg orally twice daily
Study NCT00736632 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo pill orally daily Calcium carbonate 500 mg twice daily
Study NCT01754233 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 755nm Alexandrite Laser
Description: 755nm Alexandrite Laser for epidermal and dermal pigmented lesions
Study NCT04216654 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ELISA (enzyme-linked immunosorbent assay)
Description: ELISA Principle. Enzyme-linked Immunosorbent Assays (ELISAs) combine the specificity of antibodies with the sensitivity of simple enzyme assays, by using antibodies or antigens coupled to an easily-assayed enzyme. ELISAs can provide a useful measurement of antigen or antibody concentration.
Study NCT02087475 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Irinotecan
Study NCT02087475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Study NCT02087475 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-fluorouracil
Study NCT02087475 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil
Study NCT02087475 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Local radiotherapy
Study NCT02087475 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Local radiotherapy
Study NCT02087475 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: R0 resection
Study NCT02087475 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: R0 resection
Study NCT02065960 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT)
Study NCT03185728 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: iLook Out for Child Abuse
Description: Online, interactive educational intervention that uses a video-based story-line and gamification to teach childcare providers about child abuse and mandated reporting.
Study NCT03185728 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: iLook Out for Child Abuse
Description: Online, interactive educational intervention that uses a video-based story-line and gamification to teach childcare providers about child abuse and mandated reporting.
Study NCT00822458 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vismodegib
Description: Given orally
Study NCT00822458 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Study NCT00822458 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Study NCT01828047 — intervention group
Intervention type: DEVICE
Intervention: orthogonal polarization spectral (OPS) imaging
Description: orthogonal polarization spectral (OPS) imaging allows noninvasive observation of human microcirculation in all accessible tissue surfaces
Study NCT02519530 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Teen Outreach Program
Description: The Teen Outreach Program (TOP) is a positive youth development program that uses weekly educational peer group sessions, Community Service Learning (CSL), and positive adult guidance to help youth in grades 6-12 build healthy behaviors, life skills, and a sense of purpose. For this study, TOP was implemented in traditional public high schools in Florida and delivered by local health department staff, who were trained and certified as TOP facilitators. Youth enrolled in these classes received the TOP intervention in addition to, not as a replacement for, all business-as-usual curriculum content.
Study NCT01366339 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral methylnaltrexone
Study NCT01366339 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oral placebo
Study NCT04318990 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Distal radial artery access
Description: Patients undergoing coronary angiography or angioplasty at The Heart Hospital Baylor Plano will be randomized 1:1 to distal or proximal radial access for cardiac catheterization.
Study NCT04318990 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Proximal radial artery surgery
Description: Patients undergoing coronary angiography or angioplasty at The Heart Hospital Baylor Plano will be randomized 1:1 to distal or proximal radial access for cardiac catheterization.
Study NCT03205410 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: remote ischemic preconditioning
Description: The remote ischemic preconditioning protocol described before began after anesthesia induction, and was completed prior to the start of surgery.
Study NCT03205410 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: no - remote ischemic preconditioning
Description: The sham - remote ischemic preconditioning protocol described before began after anesthesia induction, and was completed prior to the start of surgery.
Study NCT04342845 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental: Motivational interviewing Placebo Comparator: Traditional lectures
Description: Patients in the intervention group (n=117) received a four-session patient empowerment program in small groups over one month by trained nurses and doctors. he control group received traditional lectures that consisted solely of conveying healthcare information to patients.
Study NCT04342845 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Experimental: Motivational interviewing Placebo Comparator: Traditional lectures
Description: Patients in the intervention group (n=117) received a four-session patient empowerment program in small groups over one month by trained nurses and doctors. he control group received traditional lectures that consisted solely of conveying healthcare information to patients.
Study NCT02335164 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: recombinant influenza hemagglutinin
Description: recombinant influenza hemagglutinin
Study NCT00789243 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Forearm vascular study
Description: Forearm blood flow measured by venous occlusion plethysmography during interarterial infusion of substance P (2,4,8 pmol/min). Venous blood sampling via cannula in antecubital fossa.
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: daunorubicin hydrochloride
Description: Given IV during reinduction
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dexamethasone
Description: Given IV or orally during reinduction
Study NCT02335164 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Advax1
Description: Delta inulin adjuvant formulation 1
Study NCT01399606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BF2.649
Description: 5,10,20,or 40 mg per day, in a once daily scheme
Study NCT03683615 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: repair of orbital floor fractures using resorbable plates
Study NCT02633085 — intervention group
Intervention type: DEVICE
Intervention: Fixed Bearing or Mobile Bearing UKA
Description: Fixed Bearing or Mobile Bearing UKA Patients who have undergone a primary Fixed Bearing or a Mobile Bearing UKA in either knee and are at a minimum 2 years post-op.
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: doxorubicin hydrochloride
Description: Given IV during reinduction
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide
Description: Given IV during reinduction
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ifosfamide
Description: Given IV during reinduction
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: leucovorin calcium
Description: Given IV during reinduction
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mercaptopurine
Description: Given orally during reinduction
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methotrexate
Description: Given orally during reinduction
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prednisone
Description: Given intrathecally during reinduction
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: thioguanine
Description: Given orally during reinduction
Study NCT00764907 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vincristine sulfate
Description: Given IV during reinduction
Study NCT02303535 — intervention group
Intervention type: PROCEDURE
Intervention: Cardiac Surgery
Description: All patients with congential and acquired heart disease treated by cardiac surgery procedures.
Study NCT02303535 — intervention group
Intervention type: PROCEDURE
Intervention: Therapeutic cardiac catheterisations procedures
Description: All patients with congential and acquired heart disease treated by therapeutic cardiac catheterisations procedures .
Study NCT00789243 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Forearm vascular study
Description: Forearm blood flow measured by venous occlusion plethysmography during interarterial infusion of substance P (2,4,8 pmol/min). Venous blood sampling via cannula in antecubital fossa.
Study NCT03098082 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Actim Pancreatitis
Description: Actim Pancreatitis (Medix Biochemica) is a urine trypsinogen-2 dipstick test (UTDT) that uses trypsinogen-2 as a biomarker for acute pancreatitis.
Study NCT01420965 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CT-011 (Anti-PD1 Antibody)
Description: Immune Enhancer
Study NCT01420965 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sipuleucel-T (Provenge)
Description: Vaccine
Study NCT01420965 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sipuleucel-T (Provenge)
Description: Vaccine
Study NCT01420965 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Low dose- Immune Enhancer
Study NCT00862732 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive behavioural therapy
Description: Will receive a series of sessions of cognitive behaviour therapy. Delivery of CBT will be by three therapists; PI and two other Medical Officers. Each session will last for 30- 45 minutes and they will be delivered at the participant's residence (or at an alternative place of participant's choice) at two weeks intervals. They will be followed-up for three months from the cessation of CBT sessions.
Study NCT02766361 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Rehabilitation
Description: 12 weekly sessions of Combined intervention lasting 90 minutes